Henagliflozin

<!-- Clinical data --> Henagliflozin is a pharmaceutical drug for the treatment of type 2 diabetes. In China, it is approved for adult patients with type 2 diabetes to improve the glycemic control.

Henagliflozin, like other drugs of the gliflozin class, inhibits the transporter protein sodium/glucose cotransporter 2 (SGLT2) which leads to a reduction in blood glucose levels. Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'Rui Qin', query time: 0.01s Refine Results
  1. 1
    Estimating the association between cigarette and e-cigarette use patterns and SARS-CoV-2 negative conversion time: retrospective online survey in China

    Estimating the association between cigarette and e-cigarette use patterns and SARS-CoV-2 negative conversion time: retrospective online survey in China by Ying Xie, Yinghua Li, Zheng Su, Xueyan Han, Zhao Liu, Zhenxiao Huang, Anqi Cheng, Xinmei Zhou, Jinxuan Li, Rui Qin, Xiaowen Wei, Yi Liu, Xin Xia, Qingqing Song, Liang Zhao, Kian Fan Chung, Dan Xiao, Chen Wang

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: